American Academy of Pediatrics. Clinical Practice Guideline: Diagnosis and Evaluation of the Child With
Attention-Deficit/Hyperactivity Disorder, Pediatrics. 2000; 105,5: 1158-1170.

Biederman J, Faraone SV. Attention-deficit hyperactivity disorder. Lancet. 2005; 366(9481):237-48.

Edward MC, Gardner ES, Chelonis JJ, Schulz EG, Flake RA, Diaz PF. Estimates of the Validity and Utility of
the Conners’ Continuous Performance Test in the Assessment of Inattentive and/or Hyperactive-Impulsive Behaviors in Children. J Abnorm Child Psychol 2007; 35:393–404.

Jucaite A, Fernell E, Halldin C, Forssberg H, Ferde L. Reduced midbrain dopamine transporter building in male adolescents with attention-deficit/hyperactivity disorder: association between striatal dopamine makers and motor hyperactivity. Biol Psychiatry. 2005;57:229-238.

Jensen PS et. al. Findings from the NIMH multimodal treatment study of ADHD (MTA): implications and applications for primary care providers. J Dev Behav Pediatr. 2001;22(1):60-73.

Leslie, LK, et. al. Implementing the American Academy of Pediatrics Attention-Deficit/Hyperactivity Disorder Diagnostic Guidelines in Primary Care Settings. Pediatrics. 2004; 114(1):129-140.

Max J, Fox P, Lancaster J, Kochunov P, Mathews K, Manes F, Robertson B, Arndt S, Robin D. Putamen Lesions and the Development of Attention-Deficit/Hyperactivity Symptomatology. Journal of American Academy of Child and Adolescent Psychiatry. 2002; 41:5.

Perwien, AR, et. al., Stimulant Treatment Patterns and Compliance in CHildren and Adults with Newly Treated Attention-Deficit/Hyperactivity Disorder. Journal of Managed Care Pharmacy. 2004; 10(2):122-129.

Pliszka SR et. al. The Texas Children’s Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2006; 45(6):642-57.

Sanchez, RJ, et. al. Assessment of Adherence Measures with Different Stimulants Among Children and Adolescents. Pharmacotherapy. 2005; 25(7)909-917.

Waschbusch, DA, et. al. Are There Placebo Effects in the Medication Treatment of Children with Attention-Deficit Hyperactivity Disorder? Journal of Developmental and Behavioral Pediatrics. 2009; 30(2):158-168.

Anderson C, Polcari A, Lowen S, Renshaw P, Teicher M. Effects of Methylphenidate on Functional Magnetic Resonance Relaxometry of the Cerebellar Vermis in Boys With ADHD. American Journal of Psychiatry. 2002; 159:(8), 1322.

Faedda G, Teicher M. Objective Measures of Activity and Attention in the Differential Diagnosis of Childhood Psychiatric Disorders. Essential Psychopharmacology 2005; 6:239- 248.

Heiser P, Frey J, Smidt C, Sommerlad P, Wehmeier M, Hebebrand J, Remschmidt H. Objective measurement of hyperactivity, impulsivity, and inattention in children with hyperkinetic disorders before and after treatment with methylphenidate. European Child & Adolescent Psychiatry. 2004;13: 100.

Hughes, C, Bolanos, G, Silver, C, Pickering, J, D., Hum., Baker, K. Assessment of Attention and Moiton in Children with an Oral Language Disorder and Attention-Deficit/Hyperactivity Disorder. AACAP Poster Session. 2010.

Polcari A, Fourligas N, Navalta C, Teicher MH. Hyperactivity Persists in Male and Female Adults with ADHD and Remains a Highly Discriminative Feature of the Disorder. AACAP Poster Session. 2010.

Sumner, CR, Sutton, VS, Teicher, MH and Newcorn, JH. Does Placebo Response Differ Between Objective and Subjective ADHD Measures in Children with Attention-Deficit/Hyperactivity Disorder? Postgraduate Medicine. 2010; 122(5), 52-61.

Sumner, CR New Tool for Objective Assessment of ADHD: The Quotient^® ADHD System. The ADHD Report. 2010; 18(5), 6-9.

Sumner, CR. Making the diagnosis. Executive Healthcare Management. 2008.

Tabori-Kraft, Janne; Sorensen, Merete;Kerguard, Martin; Dalsgaard, Soren; Thomsen, Per Hove.Is MMAT (Quotient) useful for monitoring the effect of stimulants on hyperactivity and inattention? A brief report, European Child and Adolescent Psychiatry. May 2007.

Teicher M, Ohashi K, Vialiano G, Polcari A. Unraveling the Nature of Hyperactivity in Children with Attention-Deficit/Hyperactivity Disorder. oArch Gen Psychiatry, 2010:67(4), 388-396.

Teicher M, Polcari A, McGreenery C. Utility of Objective Measures of Activity and Attention in the Assessment of Therapeutic Response to Stimulants in Children with ADHD. Journal of Child and Adolescent Psychopharmacology. 2008:18,3, 265-270.

Teicher M, Polcari A, Foley M, Valente E, McGreenery C, Chang W, McKay G, Midha K. Methylphenidate Blood Levels and Therapeutic Response in Children with ADHD: Effects of Different Dosing Regimens. Journal of Child and Adolescent Psychopharmacology.2006; 16:(4) 416-431.

Teicher M, Lowen S, Polcari A, Foley M, McGreenery C. Novel Strategy for the Analysis of CPT Data Provides New Insight into the Effects of Methylphenidate on Attentional States in Children with ADHD. Journal of Child And Adolescent Psychopharmacology. 2004;14:2.

Teicher M, Polcari A, Anderson C, Andersen S, Lowen S, Navalta C. Rate Dependency Revisited: Understanding the Effects of Methylphenidate in Children with Attention Deficit Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology. 2003;13:1, 41.

Teicher M, Anderson C, Polcari A, Glod C, Maas L, Renshaw P.Functional Deficits in Basil Ganglia of Children with Attention-Deficit/Hyperactivity Disorder Shown with Functional Magnetic Resonance Imaging Relaxometry. Nature Medicine 2000; 6 (4):470.

Teicher M, Ito Y, Glod C, Barber N. Objective Measurement of Hyperactivity and Attentional Problems in ADHD. American Academy of Child and Adolescent Psychiatry. 1996; 35(3): 334.